Neurolance AG is rated 3 out of 5 in the category health. Read and write reviews about Neurolance AG. Our novel prevention treatment clinic for AD and Dementia involves an intervention program of non-pharma human trials of pre-symptomatic high-risk people. Neurolance is building a proprietary application to be fully integrated into our clinical protocols using Artificial Intelligence (A.I.), the latest in wearable devices and patent pending technologies to innovate AD prevention making it earlier, personalised and automated. We use state-of-art technologies, removing the need for Nurses / Care givers, replaced by clinically proven, insurance covered prevention protocols that have the potential to delay AD by 10 years.
Company size
11-50 employees